Generic Flexeril

Several companies manufacture a generic form of Flexeril. The medication comes in two strengths -- 5-mg and 10-mg tablets. The FDA has assigned the generic versions an "AB" rating, meaning they are equivalent to the brand-name medication. However, the generic versions may contain different inactive ingredients, such as fillers or dyes.

Can I Buy Generic Flexeril?

Flexeril® (cyclobenzaprine hydrochloride) is a prescription medication used to treat muscle spasms. It belongs to a group of medications known as skeletal muscle relaxants.
 
Brand-name Flexeril is manufactured by McNeil Consumer & Specialty Pharmaceuticals. However, it has come off patent and is also available as a generic.
 

Available Strengths

Generic Flexeril tablets are available in the following strengths:
 
  • Cyclobenzaprine 5 mg
  • Cyclobenzaprine 10 mg.
     

Who Makes Generic Flexeril?

The generic version of Flexeril is made by the following manufacturers:
 
  • Actavis, Inc.
  • Hawkins, Inc.
  • Major Pharmaceuticals
  • Medisca, Inc.
  • Meridian Pharmaceuticals, Inc.
  • Mutual Pharmaceutical Company, Inc.
  • Mylan Pharmaceuticals, Inc.
  • Pliva, Inc.
  • Sandoz
  • UDL Laboratories, Inc.
  • Watson Laboratories
     

Is Generic Cyclobenzaprine as Good as Flexeril?

All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications, and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All generic cyclobenzaprine 5-mg and 10-mg tablets currently available have an "AB" rating, meaning they should be equivalent to Flexeril.
 
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people who have allergies or sensitivities.
 
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
Other Articles in This eMedTV Presentation